By Susan Brinkmann, OCDS
Staff Journalist
Cardinal Daniel DiNardo, the chairman of the U.S. bishops’ Committee on Pro-Life Activities voiced “grave concern” to the U.S. Food and Drug Administration (FDA) over its move toward approving a new drug that may induce early abortions as an “emergency contraceptive.”
